Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain
Recruiting
N/A
Interventional Study
Chronic Pain
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 200 (estimated)
- Sponsor
- Saluda Medical Pty Ltd · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to test and evaluate novel treatment delivery of ECAP-controlled closed loop SCS through the incorporation of new software and/or hardware features for patients with the Evoke System.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 1\. Subject has undergone trial implant or is planning to be implanted with the Evoke System within its approved indication.
* 2\. Subject is willing and capable of giving informed consent and able to comply with study-related requirements.
Exclusion Criteria:
N/A
Contacts